🔗 Share this article

Acclaimed R&B singer D’Angelo passed away on October 14 at age 51 after a private battle with pancreatic cancer.

“The brilliant light of our household has dimmed his light for us in the present world,” his family stated. “After a lengthy and courageous struggle with the disease, we are heartbroken to declare that Michael D’Angelo Archer, known to his fans around the globe as D’Angelo, has been called home.”

D’Angelo left an indelible mark on the music industry with his innovative neo-soul sound and collaborations with renowned musicians.

He launched his debut album, “Brown Sugar,” in 1995 to instant praise. The album achieved No. 4 on the R&B charts, went platinum soon after, and received several award nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that propelled his music career into the stratosphere. The album premiered at No. 1 on each of the R&B charts and the main album chart. He won two Grammy Awards: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a sex symbol, albeit a reluctant one, in the cultural zeitgeist. The intimate portrayal showed the singer, notably stripped down to his midsection, singing directly into the lens.

D’Angelo retreated from the spotlight after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a serious car crash that put him in grave health.

More than a decade later, his third and final album, “Black Messiah” (2014), reaffirmed his enduring appeal with a further No. 1 debut on the soul music rankings and a Grammy for Best R&B Album.

Again, in his own mysterious fashion, D’Angelo had limited public outings in the following years.

The musician was announced as a top act for the 2025 music event, but his performance was canceled, due to an “unforeseen medical delay.”

Even though information is limited about D’Angelo’s health in the weeks leading up to his death, he had apparently been hospitalized for months and in palliative care for two weeks.

D’Angelo’s passing is a stark reminder of the harmful impact of pancreatic malignancy, one of the deadliest and hardest to prevent forms of the disease, on a gifted artist whose existence was cut short.

“We are grieved that he can only provide dear memories with his family, but we are eternally grateful for the heritage of deeply emotional music he has left us,” his kin said.

Pancreatic Malignancy: Lethal and Difficult to Avoid

Pancreatic cancer affects the pancreas, a small organ that generates insulin and is vital in breaking down food, among additional roles. The position and dimensions of the organ in the human system make it more difficult to detect cancer.

Although this cancer makes up only about 3% of cancer diagnoses annually in the United States, it is responsible for 7% of malignancy fatalities.

Almost 70,000 individuals will be diagnosed with this condition and about 52,000 will succumb to the illness in the year 2025.

“Pancreatic cancer is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have limited and ineffective therapies, and a narrow opportunity to make a meaningful impact on the lives of patients,” said a cancer specialist.

Since pancreatic cancer rarely causes initial signs, it’s frequently diagnosed only once the condition is late-stage. Although a patient has indicators they are often vague and may be mistaken for a several common illnesses.

“Currently, there is no good way to identify pancreatic cancer in the early stages, apart from paying attention to physical changes and consulting your doctor if there are new or unusual symptoms,” explained a health expert.

Common symptoms of this disease encompass:

• discomfort in the stomach or back
• weight loss
• jaundice
• loss of appetite
• dark urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s demise is an exception, as this malignancy is typically found in individuals in the sixty-five to seventy-five range. However, numerous malignancies, such as pancreatic cancer, have become increasingly prevalent among younger people.

“This disease diagnosed prior to fifty is considered rare, yet concerningly, doctors are noticing a rising count of younger patients affected by this disease,” commented a expert.

Family History Impacts Cancer Risk

Without effective detection methods for this malignancy, experts stressed the importance of knowing your relatives’ health background. Certain contributing elements, such as smoking and excess weight also play a role in the development of pancreatic cancer.

African Americans have the highest incidence of pancreatic cancer in the U.S. and are more prone to be found to have untreatable disease.

“The first step toward reducing one’s risk of pancreatic cancer is assessing personal risk factors. Individuals should examine their family history, genetic background, and health issues, such as diabetes, chronic pancreatitis, or overweight that may increase their susceptibility,” advised a medical professional.

Hereditary elements are associated with as much as ten percent of all pancreatic cancer cases. If a relative in your family has had this disease, you may want to consider genetic testing.

“For individuals with a family history of this condition or those having high risk genetic mutations, checking may involve advanced imaging such as magnetic resonance imaging (MRI) or internal ultrasound to detect early changes in the organ,” he explained.

For those looking to lower their chance, lifestyle changes may make a difference. The best action you can take to lower your risk of this disease is to quit smoking, and if you don’t smoke, stay away altogether.

Heavy alcohol consumption is associated with pancreatitis, a risk factor for pancreatic cancer, so reducing or abstaining from alcohol may assist reduce your risk.

Controlling your weight or losing weight may also aid decrease your susceptibility. People with excess weight are 20% more likely to get this disease. This malignancy also is more frequent in people with blood sugar issues, and reducing weight can also reduce the risk of type 2 diabetes.

In spite of this disease’s poor prognosis, there is reason for optimism.

“We are making progress with therapies and newer mixed drug treatments. There are developing targeted therapies that already are showing results,” said a expert.

For many individuals, however, awareness about this uncommon but {dev